Chris A. Liacouras, MD - Expert Perspectives on Improving Early Recognition of Eosinophilic Esophagitis and Examining the Potential Clinical Utility of Emerging Targeted Therapy

Go online to PeerView.com/FTS860 to view the activity, download
slides and practice aids, and complete the post-test to earn
credit. This activity has been designed to meet the educational
needs of gastroenterologists (pediatric and adult),
allergists/immunologists (pediatric and adult), nurses, NPs, PAs,
and other clinicians involved in the management of EoE. Upon
completion of this CE activity, participants will be able to:
Distinguish signs and symptoms of eosinophilic esophagitis (EoE)
among children and adults to enable an earlier diagnosis and
minimize complications due to uncontrolled disease, Summarize
underlying mechanisms of EoE, including the role of key cytokines
such as interleukin-4, -13, and -5 as drivers of type 2
inflammation and how this relates to potential treatment, Review
the limitations of the current standard of care for the treatment
of EoE, Apply the latest expert recommendations and clinical
evidence to the treatment of patients with EoE, particularly as
novel and emerging agents become available.